SCIRP Mobile Website
Paper Submission

Why Us? >>

  • - Open Access
  • - Peer-reviewed
  • - Rapid publication
  • - Lifetime hosting
  • - Free indexing service
  • - Free promotion service
  • - More citations
  • - Search engine friendly

Free SCIRP Newsletters>>

Add your e-mail address to receive free newsletters from SCIRP.


Contact Us >>

Article citations


R. S. Herbst, S. G. Eckhardt, R. Kurzrock, S. Ebbinghaus, P. J. O’Dwyer, M. S. Gordon, W. Novotny, M. A. Goldwasser, T. M. Tohnya, B. L. Lum, et al., “Phase I Dose-Escalation Study of Recombinant Human Apo2L/ TRAIL, a Dual Proapoptotic Receptor Agonist, in Patients with Advanced Cancer,” Journal of Clinical Oncology, Vol. 28, No. 17, 2010, pp. 2839-2846.

has been cited by the following article: